Your Account
Sort
Categories
- #EMSPVirtual2021
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- Press Releases
- Stakeholder Events
- Uncategorized
- Young People with MS
IMPRESS study: Focus on people with MS and their carers
The London School of Economics (LSE) is currently leading a study – IMPRESS – which explores the social economic costs, quality of life and…
IMPRESS study: Focus on people with MS and their carers
The London School of Economics (LSE) is currently leading a study – IMPRESS – which explores the social economic costs, quality of life and…
EMA and EUnetHTA release joint report on medicines data
The European Medicines Agency (EMA) and the European Network for Health Technology Assessment (EUnetHTA) have published a report on their joint work plan on the generation of data on medicines, pre- and post-authorisation.
EMA to bolster support for medicines targeting unmet medical needs
The European Medicines Agency (EMA) has launched, on 7 March, a scheme designed to strengthen support to medicines that target an unmet medical need – EMA Prime.
EBC: Launch of Value of Treatment project
EMSP’s partners at the European Brain Council (EBC) have launched a two-year project aimed at bridging the treatment gap in…
EBC: Launch of Value of Treatment project
EMSP’s partners at the European Brain Council (EBC) have launched a two-year project aimed at bridging the treatment gap in…
